Analytical interference with most current commercial HIV molecular assays in patients treated by idecabtagene vicleucel, a recently approved lentivirus-based chimeric antigen receptor T-cell therapy

MeSH terms

• Cell- and Tissue-Based Therapy
• HIV Infections* / diagnosis
• HIV Infections* / therapy
• Humans
• Lentivirus / genetics
• Receptors, Chimeric Antigen* / genetics
• Receptors, Chimeric Antigen* / therapeutic use